A new type of covid vaccine which can be snorted or taken as a pill has passed animal trials in Basel.
The University of Basel says the vaccine is based on a modified coronavirus that will trigger an immune response, but won’t multiply in the body.
It’s been developed with the company RocketVax.
It can also be quickly adapted to account for new variants and it’s easier to store.
Human trials are the next stage.
Heat closes Geneva paddling pools
Eight of Geneva's eleven paddling pools are now closed as the city battles bacterial contamination during the heatwave.
Soaring temps hit hospitals
Hospital rooms at the Geneva University Hospital are hitting 34 degrees - with temperatures in the cafeteria up at 40.
Crans-Montana looks to summer season after fire tragedy
Crans-Montana is hoping for a broadly stable summer, more than six months after the New Year fire at the Constellation bar.
MétéoSuisse warns of budget cuts
The federal weather service is warning that government budget cuts risk making our forecasts less accurate.
Rents rise Geneva - more than Zurich
Rents in Geneva have risen 5.3% over the past year, putting the canton well above the national average of 2.5%, according to the property platform Homegate.
Better passenger rights coming
We’re going to get stronger air passenger rights, after the European Parliament voted for a major tightening of the rules.
